| Literature DB >> 28761497 |
Ying-Ying Chang1, Chao-Ling Lin2, Li-Yin Chang1,3.
Abstract
The goal of this study is to examine the effects of aromatherapy massage on sleep quality of nurses with monthly rotating night shifts. Subjects were enrolled at a medical center in central Taiwan with overall score ≥ 5 of Pittsburgh Sleep Quality Index (PSQI) and randomly assigned to the treatment or control groups. They were validated by pretests during their first graveyard shift in the trial period and the sleep quality information was collected by using the PSQI and sleep detectors. During the second graveyard shift, the treatment group received aromatherapy massage and the control group rested in the same aromatherapy room after work. All subjects filled out the PSQI surveys and the sleep quality information was collected during massage or resting and the following night. We found that the total PSQI was significantly decreased in the treatment group following the aromatherapy massage. Specifically, the components such as subjective sleep quality, sleep disturbance, and daytime dysfunction were significantly decreased. However, there were no significant changes of average PSQI scores between the two groups before and after intervention. Taken together, our study suggested that aromatherapy massage could improve sleep quality of nurses with monthly rotating night shift.Entities:
Year: 2017 PMID: 28761497 PMCID: PMC5518528 DOI: 10.1155/2017/3861273
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Study process.
Comparison of demographics between the two groups.
| Variable | Treatment ( | Control ( |
|
| ||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| % | Mean | SD |
| % | Mean | SD | |||
| Age | 27 | 28.36 | 4.67 | 23 | 30.55 | 5.98 | −1.45 | 0.153 | ||
| Number of years at the hospital | 27 | 4.67 | 4.09 | 23 | 6.74 | 5.17 | −1.55 | 0.129 | ||
| BMI | 27 | 22.76 | 4.17 | 23 | 21.71 | 3.09 | 1.00 | 0.324 | ||
| Job title | ||||||||||
| Contract nurse | 18 | 58.10 | 13 | 41.90 | 0.54 | 0.461 | ||||
| Government employee | 9 | 47.40 | 10 | 52.60 | ||||||
| Skill advancement | 1.83a | 0.672 | ||||||||
| N | 6 | 75.00 | 2 | 25.00 | ||||||
| N1 | 7 | 53.80 | 6 | 46.20 | ||||||
| N2 | 10 | 47.60 | 11 | 52.40 | ||||||
| ≧N3 | 4 | 50.00 | 4 | 50.00 | ||||||
| Highest degree | 2.34a | 0.451 | ||||||||
| Associate | 0 | 0.00 | 2 | 100.00 | ||||||
| Bachelor | 26 | 56.50 | 20 | 43.50 | ||||||
| Master | 1 | 50.00 | 1 | 50.00 | ||||||
aFisher's exact test.
Analysis of differences in PSQI between the two groups before and after intervention.
| Variable | Treatment ( | Control ( | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pretest | Posttest | | | Pretest | Posttest | | | |||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | |||||
| Subjective sleep quality | 1.65 | 0.42 | 1.32 | 0.35 | −3.38 | 0.001 | 1.38 | 0.38 | 1.27 | 0.39 | −0.91 | 0.360 |
| Sleep latency | 1.49 | 0.81 | 1.27 | 0.64 | −1.91 | 0.056 | 1.29 | 0.87 | 1.30 | 0.69 | −0.29 | 0.771 |
| Sleep duration | 1.53 | 0.75 | 1.35 | 0.58 | −1.47 | 0.140 | 1.22 | 0.79 | 1.08 | 0.56 | −0.70 | 0.484 |
| Habitual sleep efficiency | 1.02 | 0.65 | 1.12 | 0.78 | −0.75 | 0.453 | 1.14 | 0.93 | 1.38 | 0.89 | −0.96 | 0.339 |
| Sleep disturbance | 1.18 | 0.30 | 1.01 | 0.21 | −2.99 | 0.003 | 1.12 | 0.34 | 1.02 | 0.35 | −1.12 | 0.265 |
| Use of sleeping medication | 0.11 | 0.53 | 0.14 | 0.50 | −0.82 | 0.414 | 0.02 | 0.10 | 0.01 | 0.05 | −0.45 | 0.655 |
| Daytime dysfunction | 1.92 | 0.48 | 1.42 | 0.55 | −3.57 | 0.000 | 1.90 | 0.73 | 1.51 | 0.79 | −3.08 | 0.002 |
| PSQI total score | 8.89 | 2.45 | 7.63 | 2.22 | −3.54 | 0.000 | 8.08 | 2.31 | 7.58 | 1.92 | −1.31 | 0.191 |
aWilcox signed rank test; P < 0.01 and P < 0.001.
PSQI repeated test GEE analysis (N = 50).
| Parameter | Estimated B value | Standard error | 95% Wald confidence interval | Wald Chi-square |
| |
|---|---|---|---|---|---|---|
| Upper limit | Lower limit | |||||
| Intercept | 9.52 | .63 | 8.29 | 10.76 | 228.67 | 0.000 |
| Treatment group | .40 | .87 | −1.29 | 2.10 | .22 | 0.641 |
| Control group | 0 | . | . | . | . | . |
| 4th posttest | −2.17 | .56 | −3.26 | −1.08 | 15.31 | 0.000 |
| 3rd posttest | −2.13 | .61 | −3.33 | −.93 | 12.09 | 0.001 |
| 2nd posttest | −1.30 | .61 | −2.51 | −.10 | 4.48 | 0.034 |
| 1st posttest | −2.17 | .59 | −3.33 | −1.01 | 13.49 | 0.000 |
| 4th pretest | −1.74 | .57 | −2.85 | −.63 | 9.39 | 0.002 |
| 3rd pretest | −1.78 | .43 | −2.63 | −.93 | 16.82 | 0.000 |
| 2nd pretest | −1.39 | .47 | −2.31 | −.47 | 8.72 | 0.003 |
| 1st pretest | −.87 | .47 | −1.80 | .06 | 3.37 | 0.066 |
| Prior to pretest | 0 | . | . | . | . | . |
| [Treatment Group] | −.53 | .92 | −2.33 | 1.273 | .33 | 0.565 |
| [Treatment Group] | −.76 | .87 | −2.45 | .938 | .77 | 0.381 |
| [Treatment Group] | −.55 | .81 | −2.14 | 1.043 | .45 | 0.500 |
| [Treatment Group] | .43 | .76 | −1.07 | 1.932 | .32 | 0.571 |
| [Treatment Group] | .44 | .78 | −1.08 | 1.970 | .32 | 0.570 |
| [Treatment Group] | .52 | .71 | −.86 | 1.906 | .55 | 0.458 |
| [Treatment Group] | .50 | .86 | −1.19 | 2.193 | .34 | 0.560 |
| [Treatment Group] | .17 | .68 | −1.17 | 1.507 | .06 | 0.808 |
| [Treatment Group] | 0 | . | . | . | . | . |
| [Control Group] | 0 | . | . | . | . | . |
| [Control Group] | 0 | . | . | . | . | . |
| [Control Group] | 0 | . | . | . | . | . |
| [Control Group] | 0 | . | . | . | . | . |
| [Control Group] | 0 | . | . | . | . | . |
| [Control Group] | 0 | . | . | . | . | . |
| [Control Group] | 0 | . | . | . | . | . |
| [Control Group] | 0 | . | . | . | . | . |
| [Control Group] | 0 | . | . | . | . | . |
Analysis of take-home sleep detector between the two groups before and after intervention.
| Variable | Treatment group ( | Control group ( | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pretest | Posttest |
|
| Pretest | Posttest |
|
| |||||
| Mean | SD | Mean | SD | Mean | SD | Mean | SD | |||||
| Aromatherapy room | ||||||||||||
| Subjective sleep quality | 2.99 | 0.75 | 3.57 | 0.63 | − 2.62 | .009 | 2.97 | 0.72 | 2.97 | 0.43 | −0.05 | 0.959 |
| Sleep duration (hr) | 1.17 | 0.32 | 1.09 | 0.07 | −0.79 | .427 | 1.29 | 0.65 | 1.15 | 0.27 | −0.49 | 0.625 |
| Onset time (minutes) | 13.98 | 6.09 | 18.23 | 9.60 | −1.72 | .086 | 11.33 | 5.64 | 12.08 | 6.59 | −0.84 | 0.401 |
| Deep sleep duration (hr) | 0.72 | 0.22 | 0.59 | 0.26 | −2.22 | .026 | 0.72 | 0.42 | 0.68 | 0.33 | −0.09 | 0.927 |
| Light sleep duration (hr) | 0.21 | 0.19 | 0.25 | 0.17 | −1.01 | .312 | 0.31 | 0.22 | 0.27 | 0.20 | −1.13 | 0.257 |
| Total wake/dream time (hr) | 0.19 | 0.14 | 0.23 | 0.14 | −1.92 | .055 | 0.24 | 0.25 | 0.18 | 0.11 | −0.23 | 0.821 |
| AHI (count) | 2.48 | 7.65 | 2.15 | 4.33 | −0.24 | .807 | 5.23 | 9.55 | 6.74 | 11.38 | −0.72 | 0.469 |
| Home or dorm | ||||||||||||
| Subjective sleep quality | 3.35 | 0.70 | 3.41 | 0.83 | −0.37 | .715 | 3.31 | 0.77 | 3.39 | 0.90 | −0.26 | 0.795 |
| Sleep duration (hr) | 5.96 | 2.24 | 5.93 | 1.53 | −0.14 | .889 | 5.80 | 1.67 | 5.98 | 1.59 | −0.63 | 0.527 |
| Onset time (minutes) | 27.00 | 32.41 | 28.29 | 28.00 | −0.15 | .882 | 23.89 | 14.92 | 30.45 | 22.60 | −0.83 | 0.408 |
| Deep sleep duration (hr) | 2.57 | 1.37 | 2.55 | 1.03 | −0.13 | .899 | 2.27 | 1.09 | 2.35 | 0.90 | −0.81 | 0.417 |
| Light sleep duration (hr) | 1.75 | 1.03 | 1.71 | 0.74 | −0.61 | .542 | 1.94 | 0.65 | 1.91 | 0.74 | −0.24 | 0.808 |
| Total dream time (hr) | 1.50 | 0.76 | 1.51 | 0.54 | −0.20 | .839 | 1.46 | 0.47 | 1.57 | 0.54 | −1.01 | 0.313 |
| AHI (count) | 3.72 | 4.86 | 3.63 | 4.01 | −0.34 | .737 | 5.29 | 5.68 | 5.24 | 4.96 | −0.50 | 0.614 |
aWilcox signed rank test; P < 0.05 and P < 0.01.
GEE analysis of the two groups' repeated measurement with subjective sleep quality at aromatherapy room.
| Parameter | Estimated value of B | Standard error | 95% Wald confidence interval | Wald Chi-square |
| |
|---|---|---|---|---|---|---|
| Lower limit | Upper limit | |||||
| Intercept | 2.97 | .15 | 2.68 | 3.26 | 404.76 | 0.000 |
| Treatment group | .02 | .21 | −.39 | .42 | .01 | 0.925 |
| Control group | 0 | . | . | . | . | . |
| Posttest | −.004 | .13 | −.26 | .26 | .001 | 0.978 |
| Pretest | 0 | . | . | . | . | . |
| [TreatmentGroup] | .58 | .23 | .14 | 1.03 | 6.54 | 0.011 |
| [Treatment Group] | 0 | |||||
| [Control Group] | 0 | . | . | . | . | . |
| [Control Group] | 0 | . | . | . | . | . |
| (Scale) | .42 | |||||